NAD+ and Cellular Metabolism

What Is NAD+?

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every cell of the human body. It acts as an electron carrier in the mitochondrial electron transport chain - the fundamental process by which cells convert food into ATP (cellular energy). Without NAD+, this process stops and cells die.

Beyond energy metabolism, NAD+ serves as a required substrate for sirtuins (SIRT1-7) - a family of deacetylases that regulate gene expression, DNA repair, inflammation, and stress responses. Sirtuins are often described as "longevity genes" because they are activated by caloric restriction, exercise, and other longevity-associated interventions - all of which require and deplete NAD+.

NAD+ also powers PARP (poly ADP-ribose polymerase) enzymes, which detect and repair DNA damage. Given that DNA damage accumulates with age and is central to aging hallmarks described by Lopez-Otin et al. (2013), NAD+-dependent PARP activity is directly relevant to biological aging rate.

Why NAD+ Declines With Age

NAD+ levels in human tissue decline approximately 50% between young adulthood (20s) and age 60, with the steepest decline occurring after 40. This has been documented in multiple human studies including Zhu et al. (2015) in blood NAD+ and Massudi et al. (2012) in liver and skeletal muscle.

The primary mechanisms of this decline are:

• Increased PARP activity: Accumulating DNA damage with age activates PARPs, which consume NAD+ rapidly in repair attempts
• CD38 upregulation: CD38, an NAD+-consuming enzyme involved in immune function, increases with age and chronic inflammation
• Reduced biosynthesis: Activity of NAMPT (rate-limiting enzyme in the salvage pathway) decreases with aging
• Increased inflammation: Inflammatory processes that accompany aging consume NAD+ through multiple pathways

Key Biomarkers to Track

Biomarker	Normal range	Clinical relevance
Whole blood NAD+	20-50 nmol/L (varies by lab)	Direct measure; tested pre/post supplementation
NAMPT activity	Research use only	Rate-limiting enzyme in NAD+ synthesis
NAD+/NADH ratio	Highly variable by tissue	Reflects cellular redox state and energy balance
NMN in plasma	<10 nM (basal)	Rises measurably with NMN supplementation

NAD+ Precursor Supplements

Three main dietary/supplement approaches to raising NAD+ are clinically documented:

• Nicotinamide Riboside (NR): Best human evidence. Raises blood NAD+ 40-60% at 300mg/day in multiple RCTs. Converted via NRK pathway in all tissues.
• Nicotinamide Mononucleotide (NMN): One step closer to NAD+ in biosynthesis. Strong animal data, emerging human data (2021-2022 trials). Likely effective but fewer published human studies.
• Nicotinamide (Nam): The most basic precursor and cheapest. Raises NAD+ but may inhibit sirtuins at high doses - not recommended as a primary NAD+ strategy.

Further Reading

Peer-reviewed citations informing this article:

• Elsworth et al. (2017). Nicotinamide riboside... Nat Commun. DOI: 10.1038/ncomms15042
• Zhu et al. (2015). Declining NAD+ induces a pseudohypoxic state... Cell. DOI: 10.1016/j.cell.2014.12.029
• Lopez-Otin et al. (2013). The hallmarks of aging. Cell. DOI: 10.1016/j.cell.2013.05.039
• Massudi et al. (2012). Age-associated changes in oxidative stress... PLoS One.